Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
Publication Number | Title | Priority Date |
---|---|---|
CN-113912595-A | Compound containing thiazole or thiadiazole structure and application thereof | 2021-10-12 |
US-2022002299-A1 | Tricyclic pyridone compounds as jak2 v617f inhibitors | 2020-07-02 |
WO-2022006456-A1 | Tricyclic pyridone compounds as jak2 v617f inhibitors | 2020-07-02 |
WO-2021159993-A1 | Inhibitors of interleukin-1 receptor associated kinase (irak) /fms-like receptor tyrosine kinase (flt3), pharmaceutical products thereof, and methods thereof | 2020-02-14 |
US-2021269434-A1 | Tricyclic compounds as inhibitors of kras | 2020-01-10 |
WO-2021142252-A1 | Tricyclic compounds as inhibitors of kras | 2020-01-10 |
WO-2021004535-A1 | Cinnolines as inhibitors of hpk 1 | 2019-07-11 |
WO-2021004547-A1 | Heterocyclic compounds as inhibitors of hpk1 | 2019-07-11 |
WO-2020177629-A1 | Spiro-substituted pyrimidine-fused cyclic compound, preparation method therefor and medical use thereof | 2019-03-01 |
TW-202031644-A | Benzimidazole derivative | 2018-11-06 |